These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8960102)

  • 1. Biotinylation of proteins via amino groups can induce binding to U937 cells, HL-60 cells, monocytes and granulocytes.
    Storm D; Loos M; Kaul M
    J Immunol Methods; 1996 Nov; 199(1):87-99. PubMed ID: 8960102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved method for measuring C1-r-C1-s-(C1 inh)2 complexes by an enzyme-linked immunosorbent assay.
    Mathews KP; Herschbach JH; Chambers SL; Zuraw BL
    J Clin Lab Anal; 1995; 9(3):196-203. PubMed ID: 7602428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotinylation of interleukin-2 (IL-2) for flow cytometric analysis of IL-2 receptor expression. Comparison of different methods.
    De Jong MO; Rozemuller H; Bauman JG; Visser JW
    J Immunol Methods; 1995 Jul; 184(1):101-12. PubMed ID: 7622862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of C1q, C1s and C-1 Inh synthesized by stimulated human monocytes in vitro.
    Reboul A; Prandini MH; Bensa JC; Colomb MG
    FEBS Lett; 1985 Oct; 190(1):65-8. PubMed ID: 3876244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of activation of the classical pathway of complement by human neutrophil defensins.
    van den Berg RH; Faber-Krol MC; van Wetering S; Hiemstra PS; Daha MR
    Blood; 1998 Nov; 92(10):3898-903. PubMed ID: 9808583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the synthesis of C1 subcomponents and C1-inhibitor.
    Gulati P; Lemercier C; Guc D; Lappin D; Whaley K
    Behring Inst Mitt; 1993 Dec; (93):196-203. PubMed ID: 8172568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 inhibitor-C1s complexes are internalized and degraded by the low density lipoprotein receptor-related protein.
    Storm D; Herz J; Trinder P; Loos M
    J Biol Chem; 1997 Dec; 272(49):31043-50. PubMed ID: 9388254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937.
    Randazzo BP; Dattwyler RJ; Kaplan AP; Ghebrehiwet B
    J Immunol; 1985 Aug; 135(2):1313-9. PubMed ID: 4008925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotinylation of heat shock protein 70 induces RANTES production in HEK293 cells in a CD40-independent pathway.
    Tao Y; Nishikawa S; Nomura M; Kitabatake N; Tani F
    Biochem Biophys Res Commun; 2005 Dec; 338(2):700-9. PubMed ID: 16246299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities.
    Chen CH; Lam CF; Boackle RJ
    Immunology; 1998 Dec; 95(4):648-54. PubMed ID: 9893058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses.
    Chen CH; Boackle RJ
    Clin Immunol Immunopathol; 1998 Apr; 87(1):68-74. PubMed ID: 9576012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
    Nilsson T; Bäck O
    Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.